Duane Nash

CIK: 0001591098

Transaction Breakdown

Open Market Buys (P)1 (10.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)9 (90.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMUX

IMMUNIC, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

IMUX
IMMUNIC, INC.
Jul 16, 2025
Award(A)
Stock Appreciation Right
Direct
315K shares-
IMUX
IMMUNIC, INC.
Jul 16, 2025
Award(A)
Stock Appreciation Right
Direct
315K shares-
IMUX
IMMUNIC, INC.
Jul 16, 2025
Award(A)
Stock Appreciation Right
Direct
630K shares-
IMUX
IMMUNIC, INC.
Jul 16, 2025
Award(A)
Stock Appreciation Right
Direct
630K shares-
IMUX
IMMUNIC, INC.
Jul 16, 2025
Award(A)
Stock Appreciation Right
Direct
315K shares-
IMUX
IMMUNIC, INC.
Jun 13, 2025
Purchase(P)
Direct
20K shares at avg. $0.83$17K
IMUX
IMMUNIC, INC.
Jun 5, 2025
Award(A)
Stock Option
Direct
570K shares-
IMUX
IMMUNIC, INC.
Jun 5, 2025
Award(A)
Stock Option
Direct
560K shares-
IMUX
IMMUNIC, INC.
Dec 4, 2024
Award(A)
Stock Option
Direct
300K shares-
IMUX
IMMUNIC, INC.
Dec 4, 2024
Award(A)
Stock Option
Direct
300K shares-

		Type	Shares	Price		Ownership
Jul 16, 2025	IMUX IMMUNIC, INC.	Award(A) Stock Appreciation Right	315,000	-	-	Direct
Jul 16, 2025	IMUX IMMUNIC, INC.	Award(A) Stock Appreciation Right	315,000	-	-	Direct
Jul 16, 2025	IMUX IMMUNIC, INC.	Award(A) Stock Appreciation Right	630,000	-	-	Direct
Jul 16, 2025	IMUX IMMUNIC, INC.	Award(A) Stock Appreciation Right	630,000	-	-	Direct
Jul 16, 2025	IMUX IMMUNIC, INC.	Award(A) Stock Appreciation Right	315,000	-	-	Direct
Jun 13, 2025	IMUX IMMUNIC, INC.	Purchase(P)	20,000	$0.83	$16,694	Direct
Jun 5, 2025	IMUX IMMUNIC, INC.	Award(A) Stock Option	570,000	-	-	Direct
Jun 5, 2025	IMUX IMMUNIC, INC.	Award(A) Stock Option	560,000	-	-	Direct
Dec 4, 2024	IMUX IMMUNIC, INC.	Award(A) Stock Option	300,000	-	-	Direct
Dec 4, 2024	IMUX IMMUNIC, INC.	Award(A) Stock Option	300,000	-	-	Direct

1-10 of 10 transactions

About Nash Duane

Nash Duane (SEC CIK 0001591098) files insider reports with the SEC as Executive Chairman of IMMUNIC, INC. (IMUX).

Signal8 holds 6 ownership filings by Nash Duane, all Form 4s, filed between Dec 6, 2024 and Jul 18, 2025. Those filings report 10 transactions, from Dec 4, 2024 to Jul 16, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Nash Duane's filings is in NEW YORK, NY.

Recent filings by Nash Duane

Jul 16, 2025: Grants or awards of IMUX derivative securities (5 lines, Form 4, code A).
Jun 13, 2025: Open-market purchase of IMUX shares (Form 4, code P).
Jun 5, 2025: Grants or awards of IMUX derivative securities (2 lines, Form 4, code A).
Dec 4, 2024: Grants or awards of IMUX derivative securities (2 lines, Form 4, code A).

Other insiders filing for IMMUNIC, INC. (IMUX)

How to read Form 4 transaction codes